Ruilan Wang: Clinical Trials

1 trial sponsored by Ruilan Wang, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Unknown 1
Phase 31Unknown 1

Follow Ruilan Wang: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effect of REcombinant Human Thrombopoietin (rhTPO) on Sepsis Patients With aCUte Severe thrombocytopEnia
rhTPO, Placebo - Sepsis, Thrombocytopenia
Phase 2 / Phase 3UnknownRuilan Wang2002019-04-012024-04-18

Conditions studied

Sepsis (1)  ·  Thrombocytopenia (1)

Interventions

Thrombopoietin (1)

Countries

China (1)

Results publications

PMID 31492102